Anke van den Berg
prof. dr.
I work as a clinical molecular biologist in the department of Pathology. In this function I supervise and implement advanced molecular diagnostic techniques. Within my research line, I focus on the molecular pathogenesis of B-cell Hodgkin and non-Hodgkin lymphoma. The specific fields of interest are genomic aberrations, genetic susceptibility, and the role of small and long noncoding RNAs. I have several international collaborations and am PI and co-PI in various projects.
LOSS OF HETEROZYGOSITY IN A GENE CODING FOR A THYROID-HORMONE RECEPTOR IN LUNG CANCERS
F LEDUC, H BRAUCH, C HAJJ, A DOBROVIC, F KAYE, A GAZDAR, JW HARBOUR, OS PETTENGILL, GD SORENSON, Anke van den Berg, K KOK, B CAMPLING, F PAQUIN, WEC BRADLEY, B ZBAR, J MINNA, C BUYS, J AYOUB
DIRECT MOLECULAR ANALYSIS OF A DELETION OF 3P IN TUMORS FROM PATIENTS WITH SPORADIC RENAL-CELL CARCINOMA
AH VANDERHOUT, K KOK, Anke van den Berg, JW OOSTERHUIS, B CARRITT, CHCM BUYS
A high frequency RFLP identified by an anonymous single copy genomic clone at 13q14.1-13q14.2 [HGM8 assignment no. D13S22]
Published in: Nucleic Acids Research
Access to document
10.1093/nar/15.1.382
AM Bowcock, H Scheffer, JM Hebert, JHM van den Berg, CHCM Buys